At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Oxaliplatin +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum (NORMAL-R)
In Brief
A Phase 2 clinical trial evaluating Radiation, Oxaliplatin, and 2 other interventions for Cancer of Rectum and 6 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this research study is to look at how tumors responds to a short course of radiation (5 days) followed by 8 cycles of chemotherapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer of Rectum, Cancer of the Rectum, Neoplasm, Rectum, Rectal Cancer, Rectum Cancer, Rectum Neoplasms, Adenocarcinoma of the Rectum
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartMay 2016
Primary CompletionFeb 2020
Study CompletionMar 2020
TodayJul 2026
First PostedDec 29, 2015
Enrollment StartMay 27, 2016
Primary CompletionFeb 4, 2020
Study CompletionMar 29, 2020
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 10.5 years ago
Interventions
Radiationradiation
Oxaliplatindrug
Leucovorindrug
Fluorouracildrug